Status:
NOT_YET_RECRUITING
Adaptation of REDCHIP Intervention for the Portuguese Context
Lead Sponsor:
ISPA - Instituto Universitario de Ciencias Psicologicas, Sociais e da Vida
Collaborating Sponsors:
Hospital de Santa Maria, Portugal
Hospital Dona Estefânia, Centro Hospitalar de Lisboa Central, Lisboa
Conditions:
Type 1 Diabetes
Eligibility:
All Genders
1-8 years
Phase:
NA
Brief Summary
The present Feasibility Randomized Controlled Trial (FRCT) aims to assess the acceptability and effectiveness of REDCHiP intervention, targeting parents of young children with T1D, followed in two maj...
Detailed Description
One of the principal fears experienced by parents of young children with T1D is related to the occurrence of hypoglycemia episodes. These events can occur on a daily basis (i.e., often triggered by ex...
Eligibility Criteria
Inclusion
- Primary caregivers must have a young child aged ≤ 8 years with a confirmed diagnosis of T1D for at least three months;
- Young children must be using either an continuous subcutaneous insulin infusion (CSII) or multiple daily insulin injections (MDI) and continuous glucose monitoring (CGM) for daily T1D treatment;
- Parents must have internet access and a computer, tablet or smartphone that connects to the internet.
Exclusion
- Parents with severe psychiatric diagnosis;
- Families of children with another severe chronic condition (e.g., chronic kidney disease and Crohn's disease);
- Parents who are not fluent in Portuguese.
Key Trial Info
Start Date :
April 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT07201779
Start Date
April 1 2026
End Date
December 1 2026
Last Update
October 1 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.